APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.

Bibliographic Details
Main Authors: Croucher, P, Shipman, C, Perry, M, Russell, G, Van Camp, B, Niesor, E, Bentzen, C, Vanderkerken, K
Format: Conference item
Published: 2002

Similar Items